Dr. Nitin Pal Kalia

Dr. Dr. Nitin Pal Kalia

orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 July 2012 in Journal of Antimicrobial Chemotherapy
Verified
Journal Article
Open access
PDF file
DKDr. Nitin Pal Kalia
Dr. Nitin Pal Kalia
PMPriya Mahajan
Priya Mahajan
RMRukmankesh Mehra
Rukmankesh Mehra
ANAmit Nargotra
Amit Nargotra
JSJai Parkash Sharma
Jai Parkash Sharma
IKInshad Ali Khan
Inshad Ali Khan
To delineate the role of capsaicin (8-methyl-N-vanillyl-6-nonenamide) as an inhibitor of the NorA efflux pump and its impact on invasion of macrophages by Staphylococcus aureus. Capsaicin in combination with ciprofloxacin was tested for activity against S. aureus SA-1199B (NorA overproducing), SA-1199 (wild-type) and SA-K1758 (norA knockout). The role of NorA in the intracellular invasion of S. aureus and the ability of capsaicin to inhibit this invasion was established in J774 macrophage cell lines. The three-dimensional structure of NorA was predicted using an in silico approach and docking studies of capsaicin were performed. Capsaicin significantly reduced the MIC of ciprofloxacin for S. aureus SA-1199 and SA-1199B. Furthermore, capsaicin also extended the post-antibiotic effect of ciprofloxacin by 1.1 h at MIC concentration. There was a decrease in mutation prevention concentration of ciprofloxacin when combined with capsaicin. Inhibition of ethidium bromide efflux by NorA-overproducing S. aureus SA-1199B confirmed the role of capsaicin as a NorA efflux pump inhibitor (EPI). The most significant finding of this study was the ability of capsaicin to reduce the intracellular invasion of S. aureus SA-1199B (NorA overproducing) in J774 macrophage cell lines by 2 log10. This study, for the first time, has shown that capsaicin, a novel EPI, not only inhibits the NorA efflux pump of S. aureus but also reduces the invasiveness of S. aureus, thereby reducing its virulence.

26 June 2017 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
DKDr. Nitin Pal Kalia
Dr. Nitin Pal Kalia
EHErik J. Hasenoehrl
Erik J. Hasenoehrl
NRNurlilah B. Ab Rahman
Nurlilah B. Ab Rahman
VKVanessa H. Koh
Vanessa H. Koh
MAMichelle L. T. Ang
Michelle L. T. Ang
KPKevin Pethe
Kevin Pethe
Significance: New drugs are needed to combat multidrug-resistant tuberculosis. The electron transport chain (ETC) maintains the electrochemical potential across the cytoplasmic membrane and allows production of ATP, the energy currency of any living cell. The ETC of the tubercle bacilli contains two terminal oxidases, the cytochrome bc 1 : aa 3 and the cytochrome bd oxidase. In this study, we used genetics and chemical biology approaches to demonstrate that simultaneous inhibition of both terminal oxidases stops respiration, kills nonreplicating drug-tolerant Mycobacterium tuberculosis , and eradicates infection in vivo at an extraordinarily fast rate. Exploiting this potent synthetic lethal interaction with new drugs promises to shorten tuberculosis chemotherapy.

1 April 2014 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
FMFauzia Mir
Fauzia Mir
SSSyed Shafi
Syed Shafi
MZM.S. Zaman
M.S. Zaman
DKDr. Nitin Pal Kalia
Dr. Nitin Pal Kalia
VRVikrant S. Rajput
Vikrant S. Rajput
MAM.S. Alam
M.S. Alam

4 October 2017 in Frontiers in Microbiology
Verified
Journal Article
Open access
SSSamsher Singh
Samsher Singh
DKDr. Nitin Pal Kalia
Dr. Nitin Pal Kalia
PJPrashant Joshi
Prashant Joshi
AKAjay Kumar
Ajay Kumar
PSParduman R. Sharma
Parduman R. Sharma
IKInshad Khan
Inshad Khan
This study elucidated the role of boeravinone B, a NorA multidrug efflux pump inhibitor, in biofilm inhibition. The effects of boeravinone B plus ciprofloxacin, a NorA substrate, were evaluated in NorA-overexpressing, wild-type, and knocked-out Staphylococcus aureus (SA-1199B, SA-1199, and SA-K1758, respectively). The mechanism of action was confirmed using the ethidium bromide accumulation and efflux assay. The role of boeravinone B as a human P-glycoprotein (P-gp) inhibitor was examined in the LS-180 (colon cancer) cell line. Moreover, its role in the inhibition of biofilm formation and intracellular invasion of S. aureus in macrophages was studied. Boeravinone B reduced the minimum inhibitory concentration (MIC) of ciprofloxacin against S. aureus and its methicillin-resistant strains; the effect was stronger in SA-1199B. Furthermore, time–kill kinetics revealed that boeravinone B plus ciprofloxacin, at subinhibitory concentration (0.25 × MIC), is as equipotent as that at the MIC level. This combination also had a reduced mutation prevention concentration. Boeravinone B reduced the efflux of ethidium bromide and increased the accumulation, thus strengthening the role as a NorA inhibitor. Biofilm formation was reduced by 4–8 folds of the minimal biofilm inhibitory concentration of ciprofloxacin, effectively preventing bacterial entry into macrophages. Boeravinone B effectively inhibited P-gp with half maximal inhibitory concentration (IC50) of 64.85 µM. The study concluded that boeravinone B not only inhibits the NorA-mediated efflux of quinolones but also considerably inhibits the biofilm formation of S. aureus. Its P-gp inhibition activity demonstrates its potential as a bioavailability and bioefficacy enhancer.

1 October 2011 in Journal of Medical Microbiology
Verified
Journal Article
Open access
PDF file
ZMZahid Mehmood Mirza
Zahid Mehmood Mirza
AKAshwani Kumar
Ashwani Kumar
DKDr. Nitin Pal Kalia
Dr. Nitin Pal Kalia
AZAfzal Zargar
Afzal Zargar
IKInshad Ali Khan
Inshad Ali Khan
Piperine, a trans-trans-isomer of 1-piperoyl-piperidine, was tested in combination with mupirocin for antimicrobial activity against Staphylococcus aureus strains including meticillin-resistant S. aureus. The combination markedly reduced the MIC of mupirocin and also lowered the mutation frequency. Enhanced accumulation and efflux of ethidium bromide from wild-type and mutant (Mupr-1) strains in the presence of piperine indicated that inhibition of efflux could be a possible mechanism of potentiation of mupirocin activity by piperine. The combination of piperine with mupirocin in a dermal infection model of mice showed better in vivo efficacy when compared with the commercially available formulation of 2 % mupirocin.

1 November 2008 in Bioorganic & Medicinal Chemistry
Verified
Journal Article
Closed access
PSPayare L. Sangwan
Payare L. Sangwan
JKJawahir L. Koul
Jawahir L. Koul
SKSurrinder Koul
Surrinder Koul
MRMallepally V. Reddy
Mallepally V. Reddy
NTNiranjan Thota
Niranjan Thota
GQGhulam N. Qazi
Ghulam N. Qazi